Federal Register / Vol. 70, No. 202 / Thursday, October 20, 2005 / Notices 61145 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Transplantation of 

Hepatic Cells. 

Date: November 16, 2005. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Carol J. Goter-Robinson, 

PhD., Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 748, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5452, (301) 594–7791, 

goterrobinsonc@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Small Clinical 

Grants in Digestive Diseases and Nutrition. 

Date: December 7, 2005. 

Time: 8 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Maria E. Davila-Bloom, 

PhD., Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 758, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 11, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21021 Filed 10–19–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Muscular Dystrophy Coordinating 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

inform the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Muscular Dystrophy 

Coordinating Committee. 

Date: November 9, 2005. 

Time: 8 a.m. to 3:30 p.m. 

Agenda: Topics proposed for discussion: 

(1) Activities and recent initiatives; (2) 

progress of the Senator Paul Wellstone 

Muscular Dystrophy Cooperative Research 

Centers; (3) recommendations of the MDCC 

Scientific Working Group; (4) efforts for 

translational research in muscular dystrophy; 

and (5) advances in the rare/understudied 

muscular dystrophies. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, 4300 Military Road, NW., 

Washington, DC 20015, (202) 362–9300. 

Contact Person: John D. Porter, PhD, 

Executive Secretary, Muscular Dystrophy 

Coordinating Committee, National Institute 

of Neurological Disorders and Stroke, NIH, 

6001 Executive Boulevard, NSC 2172, 

Bethesda, MD 20892, (301) 496–1917, 

porterjo@ninds.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

their statement to the Contact Person listed 

on this notice. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the MDCC 

Web site: http://www.ninds.nih.gov/research/ 

muscular_dystrophy/ 

coordinating_committee, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: October 11, 2005. 

Anthony M. Coehlo, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21023 Filed 10–19–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics: Meeting 

Pursuant to the Federal Advisory 

Committee Act, the Department of 

Health and Human Services (HHS) 

announces the following advisory 

committee meeting. 

Name: National Committee on Vital 

and Health Statistics (NCVHS) 

Time and Date: November 16, 2005, 9 

a.m.–3:30 p.m. November 17, 2005, 10 

a.m.–2 p.m. 

Place: Hubert H. Humphrey Building, 

200 Independence Avenue SW., Room 

705A, Washington, DC 20201. 

Status: Open. 

Purpose: At this meeting the 

Committee will hear presentations and 

hold discussions on several health data 

policy topics. On the morning of the 

first day the Committee will hear 

updates and status reports from the 

Department on various topics including 

activities of the HHS Data Council, and 

updates on HIPAA implementation 

including data standards, the EPrescribing Final Rule, Privacy Rule 

compliance, an the Notice of Proposed 

Rulemaking for health claims 

attachments. They will also hear an 

update on activities of the Office of the 

National Coordinator for Health 

Information Technology. In the 

afternoon the Committee will be 

updated on the status of activities being 

conducted by the Subcommittee on 

Privacy and Confidentiality on the 

National health Information Network, 

and hear a presentation on secondary 

uses of clinical data. 

On the morning of the second day the 

Committee will hear a presentation on 

health statistics and the national health 

information infrastructure and a 

discussion of data release and 

confidentiality issues led by a 

representative of the National Center for 

Health Statistics’ Board of Scientific 

Counselors. In the afternoon, there will 

be reports from the Subcommittees and 

a discussion of agendas for future 

Committee meetings. 

The times shown above are for the full 

Committee meeting. Subcommittee 

breakout sessions are scheduled for late 

in the afternoon of the first day and in 

the morning prior to the full Committee 

meeting on the second day. Agendas for 

these breakout sessions will be posted 

on the NCVHS Web site (URL below) 

when available. 

Contact Person for More Information: 

Substantive program information as 

well as summaries of meetings and a 

roster of committee members may be 

obtained from Marjorie S. Greenberg, 

Executive Secretary, NCVHS, National 

Center for Health Statistics, Centers for 

Disease Control and Prevention, 3311 

Toledo Road, Room 2402, Hyattsville, 

Maryland 20782, telephone (301) 458–

4245. Information also is available on 

the NCVHS home page of the HHS Web 

site: http://www.ncvhs.hhs.gov/, where 

further information including an agenda 

will be posted when available. 

61146 Federal Register / Vol. 70, No. 202 / Thursday, October 20, 2005 / Notices 

Should you require reasonable 

accommodation, please contact the CDC 

Office of Equal Employment 

Opportunity on (301) 458–4EEO (4336) 

as soon as possible. 

Dated: October 14, 2005. 

James Scanlon, 

Deputy Assistant Secretary for Planning and 

Evaluation (OSDP), Office of the Assistant 

Secretary for Planning and Evaluation. 

[FR Doc. 05–20990 Filed 10–19–05; 8:45am] 

BILLING CODE 4151–05–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Statement of Organization, Functions, 

and Delegations of Authority 

Part N, National Institutes of Health, 

of the Statement of Organization, 

Functions, and Delegations of Authority 

for the Department of Health and 

Human Services (HHS) (40 FR 22859, 

May 27, 1975, as amended most recently 

at 69 FR 64081, November 3, 2004, and 

redesignated from Part HN as Part N at 

60 FR 56606, November 9, 1995), is 

amended as set forth below to reflect the 

consolidation of acquisitions activities 

at the National Institutes of Health 

(NIH). This change is designed to 

strengthen NIH’s administrative 

structure in order to meet the goals and 

mission of NIH. The proposed 

reorganization is consistent with the 

agreement reached between HHS and 

NIH on consolidation of the acquisitions 

function. 

Section N–B, Organization and 

Functions, under the heading National 

Cancer Institute (NC, formerly HNC), 

Office of the Director, Office of 

Management, is amended as follows: 

Office of Acquisitions (NC17B, 

formerly HNC17B). (1) Manages and 

conducts a comprehensive program of 

all research and development 

contracting, non-research and 

development contracting, station 

support contracting, commercial item 

acquisitions using simplified 

acquisition procedures, GSA Federal 

Supply Schedule acquisitions and 

simplified acquisitions for customer 

institutes and centers (IC). (2) Provides 

advice and assistance regarding all 

phases of the acquisition cycle from 

planning to closeout with the purpose of 

accomplishing all acquisitions needed 

for the scientific mission and all related 

acquisitions required by its customers. 

Treatment and Biology Sciences 

Branch (NC17B2, formerly HNC17B2). 

(1) Participates in planning research/ 

research support contract programs for 

the Division of Cancer Treatment and 

Diagnosis, the Division of Cancer 

Biology, and the Center for Cancer 

Research; (2) advertises proposed 

acquisitions; (3) assists in reviewing 

contract proposals submitted in 

response to Requests for Proposals 

(RFPs); (4) negotiates and makes 

contract awards; and (5) manages postaward business aspects of contracts, and 

assists Project Officers in managing 

scientific aspects of those contracts. 

Purchasing and Support Acquisition 

Branch (NC17B3, formerly HNC17B3). 

(1) Participates in the planning for nonresearch acquisitions for the NCI; (2) 

advertises, solicits proposals, assists in 

review, negotiations, and in making 

awards; (3) manages all business related 

aspects of the awards during the postaward phase, and assists Project Officers 

as necessary in their oversight and 

management of those awards. 

Prevention, Control, and Population 

Sciences Branch (NC17B4, formerly 

HNC17B4). (1) Participates in planning 

research/research support contract 

programs for the Division of Cancer 

Prevention and the Division of Cancer 

Control and Population Sciences; (2) 

advertises proposed acquisitions; (3) 

assists in reviewing contract proposals 

submitted in response to Requests for 

Proposals (RFPs); (4) negotiates and 

makes contract awards; and (5) manages 

post-award business aspects of 

contracts, and assists Project Officers in 

managing scientific aspects of those 

contracts. 

Epidemiology and Support Branch 

(NC17B5, formerly HNC17B5). (1) 

Participates in planning research/ 

research support contract programs for 

the Division of Cancer Epidemiology 

and Genetics and the Office of the 

Director, NCI; (2) advertises proposed 

acquisitions; (3) assists in reviewing 

contract proposals submitted in 

response to Requests for Proposals 

(RFPs); (4) negotiates and makes 

contract awards; and (5) manages postaward business aspects of contracts, and 

assists Project Officers in managing 

scientific aspects of those contracts. 

FCRDC Management Operations and 

Support Branch (NC17B6, formerly 

HNC17B6). (1) Participates in planning 

the research and research support 

contract programs for the National 

Cancer Institute—Frederick Cancer 

Research and Development Center 

(NCI–FCRDC; also, Center); (2) directs 

the administrative and business 

operations of the Center; (3) administers 

a system of research contracts for the 

management and operation of the 

Center; (4) develops acquisition plans 

and conducts recompetitions, 

evaluations, and awards of the contracts 

that support the operation of the Center; 

(5) manages the utilization of space, the 

maintenance of all buildings and 

grounds, and the use and provision of 

other resources and services needed by 

the research programs at the FCRDC; 

and, (6) assists the Office of the Director, 

NCI, in managing the scientific aspects 

of those contracts. 

Section N–B, Organization and 

Functions, under the heading National 

Heart, Lung, and Blood Institute (NH, 

formerly HNH), Division of Extramural 

Affairs, is amended as follows: 

Office of Acquisitions (NH54, formerly 

HNH54). (1) Manages and conducts a 

comprehensive program of all research 

and development contracting, nonresearch and development contracting, 

station support contracting, commercial 

item acquisitions using simplified 

acquisition procedures, GSA Federal 

Supply Schedule acquisitions and 

simplified acquisitions for customer ICs. 

(2) Provides advice and assistance 

regarding all phases of the acquisition 

cycle from planning to closeout with the 

purpose of accomplishing all 

acquisitions needed for the scientific 

mission and all related acquisitions 

required by its customers. 

Heart, Lung, and Vascular Diseases 

Branch (NH542, formerly HNH542). (1) 

Plans, manages and carries out research 

and development contracting activities 

in support of the National Heart, Lung, 

and Blood Institute (NHLBI) and its 

Customer ICs’ scientific missions, 

including the solicitation, negotiation, 

coordination, awarding, and monitoring 

of all actions; (2) works with program 

staff and provides advice and guidance 

to support their research activities in the 

most effective and efficient manner; (3) 

develops guidelines, procedures, and 

internal controls to ensure proper and 

continuing implementation of NIH and 

other applicable policies, laws and 

regulations; (4) coordinates with other 

Branches within the NHLBI Office of 

Acquisitions and elsewhere at NIH to 

develop new approaches and identify 

and implement best practices; and (5) 

provides liaison support and 

representation to the greater NIH 

acquisition community. 

Blood Diseases and Resources/NIAMS 

Branch (NH544, formerly HNH544). (1) 

Plans, manages and carries out research 

and development contracting activities 

in support of the NHLBI and its 

Customer ICs’ scientific missions, 

including the solicitation, negotiation, 

coordination, awarding, and monitoring 

of all actions; (2) works with program 

staff and provides advice and guidance 

to support their research activities in the 

most effective and efficient manner; (3) 

develops guidelines, procedures, and